Healthcare Sector Earnings Signals
Operator Signal breakdown for 38 Healthcare companies based on SEC EDGAR filings. The Healthcare sector is predominantly in tailwind mode.
All Healthcare Companies
| Company | Ticker | Signal | Revenue | Rev Growth | EPS |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | TAILWIND | $19.8B | +73.1% | $8.26 |
| AbbVie Inc. | ABBV | TAILWIND | $16.6B | +10.0% | $1.02 |
| Stryker Corporation | SYK | TAILWIND | $7.2B | +11.4% | $2.20 |
| Edwards Lifesciences | EW | TAILWIND | $1.6B | +19.0% | $0.66 |
| Waters Corporation | WAT | TAILWIND | $932.4M | +6.8% | $3.77 |
| UnitedHealth Group Inc. | UNH | NEUTRAL | $111.7B | +10.8% | $6.90 |
| CVS Health Corporation | CVS | NEUTRAL | $100.4B | +5.2% | $2.30 |
| Cigna Group | CI | NEUTRAL | $68.5B | +7.5% | $6.26 |
| Elevance Health | ELV | NEUTRAL | $50.2B | +11.3% | $8.00 |
| HCA Healthcare | HCA | NEUTRAL | $19.1B | +9.3% | $7.15 |
| Merck & Co. Inc. | MRK | NEUTRAL | $16.3B | -2.2% | $-1.72 |
| Pfizer Inc. | PFE | NEUTRAL | $14.5B | -18.4% | $0.47 |
| Bristol-Myers Squibb | BMY | NEUTRAL | $11.5B | -3.4% | $1.31 |
| Abbott Laboratories | ABT | NEUTRAL | $11.2B | +5.0% | $0.61 |
| Medtronic plc | MDT | NEUTRAL | $9.0B | +7.3% | $0.89 |
| Becton Dickinson | BDX | NEUTRAL | $4.7B | -8.8% | $-1.11 |
| Biogen Inc. | BIIB | NEUTRAL | $2.5B | +0.5% | $2.15 |
| Zoetis Inc. | ZTS | NEUTRAL | $2.3B | -5.3% | $1.42 |
| Agilent Technologies | A | NEUTRAL | $1.8B | +13.9% | $1.07 |
| Illumina Inc. | ILMN | NEUTRAL | $1.1B | +4.8% | $0.87 |
| Mettler-Toledo | MTD | NEUTRAL | $1.0B | +8.8% | $10.57 |
| Bio-Techne Corporation | TECH | NEUTRAL | $311.4M | +4.8% | $0.32 |
| Johnson & Johnson | JNJ | NEUTRAL | N/A | N/A | $2.14 |
| Thermo Fisher Scientific | TMO | NEUTRAL | N/A | N/A | $4.43 |
| Danaher Corporation | DHR | NEUTRAL | N/A | N/A | $1.45 |
| Amgen Inc. | AMGN | NEUTRAL | N/A | N/A | $3.34 |
| Gilead Sciences Inc. | GILD | NEUTRAL | N/A | N/A | $1.61 |
| Boston Scientific | BSX | NEUTRAL | N/A | N/A | $0.90 |
| McKesson Corporation | MCK | NEUTRAL | N/A | N/A | $9.59 |
| Regeneron Pharmaceuticals | REGN | NEUTRAL | N/A | N/A | $6.75 |
| Vertex Pharmaceuticals | VRTX | NEUTRAL | N/A | N/A | $4.02 |
| IQVIA Holdings | IQV | NEUTRAL | N/A | N/A | $1.61 |
| ResMed Inc. | RMD | NEUTRAL | N/A | N/A | $2.74 |
| DexCom Inc. | DXCM | NEUTRAL | N/A | N/A | $0.51 |
| Align Technology | ALGN | NEUTRAL | N/A | N/A | $1.57 |
| Moderna Inc. | MRNA | NEUTRAL | N/A | N/A | $-3.40 |
| Incyte Corporation | INCY | NEUTRAL | N/A | N/A | $1.47 |
| IDEXX Laboratories | IDXX | MIXED | $1.1B | +16.9% | $3.47 |
What Healthcare Signals Mean for Operators
The Healthcare sector is sending mixed signals. Some companies growing, some flat, some declining. This usually indicates the sector is in transition. Look for the specific companies and sub-segments within healthcare that are outperforming to find opportunities.
Frequently Asked Questions
The Healthcare sector has 5 companies showing tailwinds, 0 showing headwinds, 32 neutral, and 1 mixed. Overall, the sector leans positive with more companies in growth mode.
Operator Signals are based on revenue trajectory from SEC EDGAR filings. Tailwind means revenue is accelerating, Headwind means declining, Neutral means steady-state, and Mixed means inconsistent quarter-over-quarter patterns. For the Healthcare sector, we track 38 companies.
Eli Lilly and Company, AbbVie Inc., Stryker Corporation are among the Healthcare companies showing the strongest tailwind signals based on recent earnings data.
/methodology
The this entity record above pulls directly from SEC EDGAR 8-K filings. What follows is the per-entity context — how this entity sits in the broader U.S. public-company earnings disclosures distribution and which underlying factors drive the headline numbers.
Every number on this page links back to SEC EDGAR 8-K filings; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. public companies. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.
Source: SEC EDGAR 10-K filings, 2026.